share

Moxnidazole CAS NO 52279-59-1


Unit Price:

CAS No.:52279-59-1

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Moxnidazole CAS NO 52279-59-1 is a synthetic nitroimidazole derivative with significant antimicrobial and antiprotozoal activity. This compound is a critical intermediate in the synthesis of advanced pharmaceutical agents, particularly those targeting anaerobic bacterial and protozoal infections. It is essential for research institutions and pharmaceutical manufacturers engaged in developing new therapeutic formulations and studying antimicrobial mechanisms.

Application

  • Pharmaceutical Intermediate: Primary use as a key building block in the synthesis of nitroimidazole-based APIs (Active Pharmaceutical Ingredients).
  • Antiprotozoal Drug Research: Serves as a core structure for developing new treatments against amoebiasis, giardiasis, and trichomoniasis.
  • Antibacterial Agent Development: Used in R&D for creating novel compounds effective against anaerobic bacteria, including those involved in periodontal and abdominal infections.
  • Veterinary Medicine: Investigated for potential applications in veterinary antiprotozoal and antimicrobial formulations.
  • Biochemical Research: Utilized as a standard or reference compound in microbiological and pharmacological studies.
  • Chemical Synthesis: Acts as a versatile precursor for further chemical modifications to explore new bioactive molecules.

Basic Information

Product Name Moxnidazole
CAS No. 52279-59-1
Molecular Formula C8H11N3O3
Molecular Weight 197.19 g/mol
Synonyms 1-(2-Hydroxyethyl)-2-methyl-5-nitroimidazole; Moxnidazol; Moxnidazolum; 2-Methyl-1-(2-hydroxyethyl)-5-nitro-1H-imidazole; 1H-Imidazole, 2-methyl-1-(2-hydroxyethyl)-5-nitro-; SQ 16950; SQ-16950; NSC 190939
EINECS Contact for details

Quality Control

Our Moxnidazole is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. The product undergoes comprehensive analytical testing, including identification, assay, and impurity profiling, to meet the stringent requirements for pharmaceutical intermediate use. Certificates of Analysis (COA) documenting purity, physical characteristics, and test results are provided with each shipment and are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from heat, sparks, and open flame. The container should be kept tightly sealed to protect from moisture.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to reference spectrum
Assay (HPLC) ≥ 98.0%
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%
Related Substances (HPLC) Total impurities ≤ 2.0% Any single impurity ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.